Reddit’s Moons Breakout Soon!!!Hello guys,
Reddit Moons are in this downtrend and as you can see it respected the support resistance lines, Moons can be bought on MoonsSwap.
Moons MarketCap is about 3 Million $ which is literally nothing for a crypto community of 3 Million members .
I expect the Mainnet to come at EOY or early 2022, predicted market cap is about 600 Million to 3 Billion $ which is 100-500x !!!
DYOR.
Reddittraders
Why $DOGZ Skyrocketed YesterdayWhy $DOGZ Skyrocketed Yesterday
There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media.
$DOGZ shares were buoyed — thanks to discussions and speculation on Twitter and Twitter hashtags at the start of the month..
AMCWhat a shitty day across the board. SNDl hurts too. With that said. I’m still here with All my positions. AMC... idk what to say anymore I bought the 5.5 2/19 C for 60$ close to close.
But I’m fine with losing 60$ if it comes to it
Why, you ask? This must rampant market speculation. And it is... but, something interesting developed on the daily.
For my TA professors, correct me if I’m wrong, but It looks like we just finished printing a triple inside day.
If that’s what it is, this could possibly mean it’s gearing up for a large move. The fact the last 2 daily’s are slightly bullish is hopeful. But at this point I would be surprised by nothing. G/l all
Should You Buy This Hot Reddit Stock?After GameStop's spectacular short squeeze, investors are now wondering if other heavily shorted stocks that are popular among contrarian Reddit investors, such as CEL-SCI.
As it turns out, discipline becomes paramount when the value of one's holdings goes up so high and so fast.
CEL-SCI is a development-stage biotech that is seeking to develop a novel immunotherapy treatment, Multikine, for head and neck cancer. Despite its noble goals, the company has its fair share of skeptics: Nearly 30% of its shares are shorted.
Multikine is CEL-SCI's only late-stage candidate. The experimental therapy is going through the final stages of phase 3 data collection and statistical analysis, with results expected any day. Multikine's phase 3 clinical trial has been going on for a decade, even though it was supposed to conclude in December 2015. The discrepancy between the actual and estimated trial completion time has caused CEL-SCI to become a contested stock.
All of this matters because large-cap biotechs can acquire development-stage competitors that successfully bring just one immuno-oncology therapy to market for more than $20 billion. CEL-SCI's market cap is just about $850 million, so the stock would without a doubt become a multi-bagger if it can bring Multikine past the finish line. Likewise, since it only has about $40.5 million in assets and negligible revenue, it will likely trade down to zero if Multikine disappoints.
www.fool.com
XAUUSD SHORT ANALYSIS TO 1815This analysis is a similar move to price action from the first few days of February 2020. Market most of the time repeats itself & this market structure is setting up nicely for another bearish move. Technically & fundamentally the move makes sense as the DXY & USDJPY, which correlates negatively is gaining strength which works as a confluence to my Gold sells. However, be careful as it will be a Monday and start of a new month so could expect choppiness and market manipulation.
I will be cashing into this move on behalf of my Account Management investors ONLY if I see a rejection around my entry zone.
